Pfizer (PFE)

R&D Expense Growth

6.93%

Quarterly · Period ending:

PFE logo

PFE R&D Expense Growth

Latest reported6.93%
PFE Quarterly R&D Growth (QoQ) (0.00% → 6.93%)
High-resolution chart · PNG

PFE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
6.9281%
-23.1422%
-13.1606%
61.1134%
12.1156%
-27.7759%
17.6218%
-4.148%
7.9032%
-10.5662%
3.393%
2.016%
5.413%
-31.0097%
34.0875%
-4.2274%
22.3381%
-61.0989%
120.6266%
19.741%
12.2869%
-40.5131%
45.8025%
10.7952%
23.7329%
-40.4051%
23.4211%
24.5221%
7.9599%
-30.4918%
22.061%
11.676%
3.0512%
-24.6094%
24.5405%
4.1667%
4.4092%
-32.0144%
33.6538%
7.0938%
0.9821%
-26.2777%
36.3531%
-0.692%
-8.0106%
-41.259%
78.0799%
2.4446%
8.3795%
-10.381%
11.3092%
6.3399%
-15%
-15.7303%
7.8243%
16.598%
-18.0019%
-20.1849%
18.6472%
-2.1904%
6.9823%
-25.4811%
27.8943%
0.3201%
-1.752%
-22.7352%
76.5319%
-4.8397%
0.5865%
-25.9661%
22.1751%
-4.12%
9.7711%
-20.7522%
13.0565%
-7.6674%
30.03%
-30.9701%
26.8139%
9.1848%
9.6977%
-21.425%
13.3483%
-4.9067%
6.2925%
-24.2268%
23.3051%
3.7933%
10.3093%
-28.8611%
23.3635%
9.4351%
40.9688%
-16.2887%
15.2019%
0.4773%
4.6628%
-20.7261%
27.5253%
6.4516%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.